Changing the Subject (Part 2): Turning Turing Around By Offering A “National Center Of Pharmaceutical Supply”
This article was originally published in RPM Report
Rather than try to “win” the drug pricing debate, the biopharma sector may be better served by coming up with new ideas to change the subject. We outlined our case for taking this approach – and the model for ideas that serve that goal – here. Now we offer the first proposal: a national center for off-patent pharmaceutical production.
Register for our free email digests: